参考文献/References:
[1] MOHR F W,MORICE M C,KAPPETEIN A P,et al.Coronary artery bypass graft surgery versus coronary intervention in patients with three-vessel disease and left main coronary disease:5-year follow-up of the randomized,clinical SYNTAX trial[J].Lancet,2013,381(9867):629-638.
[2] 中华医学会心血管病学分会介入心脏病学组,中华心血管病杂志编辑委员会.中国经皮冠状动脉介入治疗指南2012[J].中华心血管病杂志,2012,40(4):271-277.
[3] 玉献鹏,吕树铮,何继强,等.无保护左主干病变患者血运重建术的长期预后[J].中华心血管病杂志,2015,43(5):399-403.
[4] 姚海木,孙同文,张晓娟,等.急性冠脉综合征患者植入国产药物支架的长期疗效和安全性分析[J].中华急诊医学杂志,2015,24(1):61-67.
[5] FAJADET J,CHIEFO A.Curent management of left main coronary artery disease[J].Eur Heart J,2012,33(1):36-50b.
[6] IZUMIKAWA T,SAKAMOTO S,TAKESHITA S,et al.Outcomes of primary percutaneous coronary intervention for acute myocardial infarction with unprotected left main coronary artery occlusion[J].Catheter Cardiovasc Interv,2012,79 (7):1111-1116.
[7] Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC),European Association for Cardio-Thoracic Surgery (EACTS).2014 ESC/EACTS guidelines on myocardial revascularization[J].Eur Heart J,2014,35 (37):2541-2619.
[8] KIM W J,KIM Y H,PARK D W,et al.Comparison of single-versus two-stent techniques in treatment of unprotected left main coronary bifurcation disease[J].Catheter Cardiovasc Interv,2011,77(6):775-782.
[9] PALMERINI T,MARZOCCHI A,TAMBURINO C,et al.Impact of bifurcation technique on 2-year clinical outcomes in 773 patients with distal unprotected left main coronary artery stenosis treated with drug-eluting stents[J].Circ Cardiovasc Interv,2008,1(3):185-192.
[10] 张颖,谷国强,崔炜.冠状动脉左主干远端病变介入治疗的预后因素[J].临床荟萃,2013,28(12):1425-1427.
[11] PARMA A,FIOIRLLI R,DE FELICE F,et al.Early and mid-term clinical outcome of emergency PCI inpatients with STEMI due to unprotected left main coronary artery disease[J].J Interv Cardiol,2012,25(3):215-222.
[12] BUSZMAN P E,BUSZMAN P P,BANASIEWICZ-SZKRóBKA I,et al.Left main stenting in comparison with surgical revascularization:10-year outcomes of the (left main coronary artery stenting) LE MANS trial[J].JACC Cardiovasc Interv,2016,9(4):318-327.
相似文献/References:
[1]吕风华,张素荣,张跃光,等.冠状动脉粥样硬化性心脏病合并充血性心力衰竭患者血浆脑钠肽水平的检测[J].新乡医学院学报,2007,24(06):581.
[2]廖燕.老年冠状动脉粥样硬化性心脏病患者心功能与肺动脉压和心电指标的关系[J].新乡医学院学报,2012,29(09):696.
[3]郭鹏,李继红.不同类型冠状动脉粥样硬化性心脏病患者血浆D-二聚体和纤维蛋白原水平变化[J].新乡医学院学报,2012,29(09):698.
[4]李永锋,许志强,韩 鹏,等.冠状动脉粥样硬化性心脏病合并阻塞性睡眠呼吸暂停低通气综合征的临床分析 [J].新乡医学院学报,2012,29(10):784.
[5]舒 毅,陈幼萍,曾春平,等. 2型糖尿病合并冠状动脉粥样硬化性心脏病患者下肢血管病变相关因素分析[J].新乡医学院学报,2015,32(08):785.
[6]杨亚明,赵国安,冯春瑜,等.冠状动脉粥样硬化性心脏病患者的血脂代谢机制及药物治疗研究进展[J].新乡医学院学报,2021,38(10):996.[doi:10.7683/xxyxyxb.2021.10.020]
[7]许明发,王帅飞,苏国宝,等.不同血运重建方式治疗冠状动脉粥样硬化性心脏病合并左心室功能不全的早期疗效比较[J].新乡医学院学报,2018,35(11):1018.[doi:10.7683/xxyxyxb.2018.11.018]
XU Ming-fa,WANG Shuai-fei,SU Guo-bao,et al.Comparison of early outcomes of two kinds of revascularization on the patients with coronary heart disease complicated with left ventricular dysfunction[J].Journal of Xinxiang Medical University,2018,35(6):1018.[doi:10.7683/xxyxyxb.2018.11.018]
[8]欧红萍,李 彬,周凤勤.颈动脉超声检查联合血清超敏C 反应蛋白水平检测在冠状动脉粥样硬化性心脏病诊断中的应用[J].新乡医学院学报,2014,31(10):825.[doi:10.7683/xxyxyxb.2014.10.016]
[9]王 一.冠状动脉粥样硬化性心脏病合并二尖瓣疾病和心房颤动患者同期行冠状动脉搭桥联合二尖瓣置换术和双极射频消融术疗效观察[J].新乡医学院学报,2019,36(2):155.[doi:10.7683/xxyxyxb.2019.02.013]
WANG Yi.Clinical effect of coronary artery bypass grafting and mitral valve replacement and bipolar radiofrequency ablation on the patients with coronary atherosclerotic heart disease combined with mitral valve disease and atrial fibrillation[J].Journal of Xinxiang Medical University,2019,36(6):155.[doi:10.7683/xxyxyxb.2019.02.013]
[10]王 超,袁 宇.冠状动脉粥样硬化性心脏病患者肠道菌群丰度与血脂和血尿酸水平的相关性[J].新乡医学院学报,2019,36(7):623.[doi:10.7683/xxyxyxb.2019.07.006]
WANG Chao,YUAN Yu.Correlation between gut flora abundance and blood lipid,blood uric acid levels in patients with coronary atherosclerotic heart disease[J].Journal of Xinxiang Medical University,2019,36(6):623.[doi:10.7683/xxyxyxb.2019.07.006]